Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Feb 24, 2021 4:10pm
114 Views
Post# 32650103

RE:I am getting the impression

RE:I am getting the impressionI dont think such deal exists,But it is fair to assume that they know that they got a great deal since according to my calculation they not only acquired 3.1 million shares as part of the Units from the Offering they also acquired and additionnal 4.3 million shares in the open market,,,,I dont know for sure if the latter were acquired pre or post Offering but I presume that  was post Offering ,,,,,Of course with such a large number of shares they are interested to see the SP appreciate ,,,,,,you are implying some kind of manipulation today by this large shareholder and I dont buy it but it does not mean that there is not other manipulators ahead of the CC to get the temperature down but IDK

SPCEO1 wrote: our new large shareholder may have had a deal with THTX that if they accepted the low ball share offering price, they would do their best to average up a nd get the share price back to where it was just before the deal by the time tomorrow's confernce call is held.


<< Previous
Bullboard Posts
Next >>